Drug intelligence / Profile preview

Sante Beauteye

Development stage
Unknown
Lead developer
Santen Pharmaceutical
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Sante Beauteye is a premium over-the-counter (OTC) ophthalmic solution developed and manufactured by Santen Pharmaceutical Co., Ltd. Classified as a Class 2 OTC medicine in Japan, it is formulated to address eye fatigue, redness, and irritation caused by modern environmental stressors such as digital screen use and UV exposure. The product contains a combination of five active ingredients: taurine to enhance ocular metabolism, chondroitin sulfate sodium to protect and moisturize the cornea, vitamin B12 (cyanocobalamin) to relieve ciliary muscle strain, tetrahydrozoline hydrochloride to reduce conjunctival congestion through vasoconstriction, and chlorpheniramine maleate to alleviate itching and inflammation. It is widely recognized for its distinctive red color and elegant packaging designed to resemble a perfume bottle.

Brand names
Sante Beauteye
02

Targets

ADRA1A (α1A)ADRA2A (α2A)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Sante Beauteye.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sante Beauteye.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call